%0 Journal Article %A Chileshe Pule %A Kunda Ndashe %A Ruth Mfune %A Abigail Chilumunda %A Grace Mwanza %A Bernadette Mumba %A Lillian Mutesu Silavwe %A Bernard Mudenda Hang’ombe %T A Survey of Potential Bacterial Hazards in Salad Vegetables Sold in Lusaka District, Zambia, in 2018 %D 2020 %R 10.1101/2020.06.07.20124644 %J medRxiv %P 2020.06.07.20124644 %X Salad vegetables are a source of fresh nutrition and can also serve a vehicle for foodborne pathogens. This was a cross sectional study conducted in February and March 2018 aimed at isolating some enteropathogens from some salad vegetables.Ten samples of each salad vegetable (carrots, cabbage, cucumbers and tomatoes) were collected from two supermarkets and two open-markets. A total of 160 samples were collected and analysed microbiologically for presence of Shigella spp, Vibrio spp and Salmonella spp. The isolated bacteria were identified by conventional biochemical tests.Vibrio spp were isolated from all the vegetables that were collected from both the two open markets (62.5% and 72.5%) and two supermarkets (67.5% and 77.5%), with the highest isolation rate recorded in cabbages. The frequency of occurrence of Shigella spp and Salmonella spp was higher in supermarkets (50% and 65%; 50% and 15%) than in the open markets (10% and 7.5%; 10% and 35%), respectively.The present study revealed the presence of potential bacterial hazards in salad vegetables sold in both open markets and supermarkets in Lusaka district. The isolated bacterial pathogens are aetiological agents of diarrheal disease that even at low dose could be infectious for sensitive populations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was funded by the authorsAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:ERES Converge (Private REB) 33 Joseph Mwilwa Road Rhodes Park, Lusaka Tel: +260 955 155 633 Tel: +260 955 155 634 Cell: +260 966 765 503 eresconverge{at}yahoo.co.ukAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe authors confirm that the data supporting the findings of this study are available within the article %U https://www.medrxiv.org/content/medrxiv/early/2020/06/09/2020.06.07.20124644.full.pdf